{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:59:09Z","timestamp":1793721549515,"version":"4.6.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.neuropharm.2014.11.018","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T11:16:19Z","timestamp":1418469379000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":271,"special_numbering":"PB","title":["Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment"],"prefix":"10.1016","volume":"96","author":[{"given":"Sylvia","family":"Lombardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Maskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.11.018_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib2","doi-asserted-by":"crossref","first-page":"11175","DOI":"10.1074\/jbc.M113.453746","article-title":"Impact of sustained exposure to \u03b2-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing \u03b14\u03b22 nicotinic acetylcholine receptors","volume":"288","author":"Arora","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer's disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies","volume":"68","author":"Auld","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/neu.10116","article-title":"Nicotinic \u03b17 receptors: synaptic options and downstream signaling in neurons","volume":"53","author":"Berg","year":"2002","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0361-9230(82)90101-0","article-title":"Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis","volume":"8","author":"Bigl","year":"1982","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1301189","article-title":"SSR180711, a novel selective \u03b17 nicotinic receptor partial agonist: (1) binding and functional profile","volume":"32","author":"Biton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/brain\/99.3.459","article-title":"Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies","volume":"99","author":"Bowen","year":"1976","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0896-6273(00)80616-9","article-title":"Allosteric receptors after 30 years","volume":"21","author":"Changeux","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib15","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","article-title":"\u03b2-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal \u03b17 nicotinic acetylcholine receptors: In\u00a0vitro and in\u00a0vivo mechanisms related to Alzheimer's disease","volume":"21","author":"Dineley","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib16","doi-asserted-by":"crossref","first-page":"25056","DOI":"10.1074\/jbc.M200066200","article-title":"\u03b2-amyloid peptide activates \u03b17 nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"277","author":"Dineley","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib17","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1523\/JNEUROSCI.23-17-06740.2003","article-title":"\u03b2-amyloid regulation of presynaptic nicotinic receptors in rat Hippocampus and neocortex","volume":"23","author":"Dougherty","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib18","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1523\/JNEUROSCI.6159-08.2009","article-title":"Deletion of the \u03b17 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease","volume":"29","author":"Dziewczapolski","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1755-5949.2012.00317.x","article-title":"Cotinine: a potential new therapeutic agent against Alzheimer's disease","volume":"18","author":"Echeverria","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2011-102136","article-title":"Cotinine reduces amyloid-\u03b2 aggregation and improves memory in Alzheimer's disease mice","volume":"24","author":"Echeverria","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.bmcl.2014.02.008","article-title":"Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease","volume":"24","author":"Gao","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426592","article-title":"Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine","volume":"52","author":"Ghoneim","year":"1977","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tins.2005.04.009","article-title":"Desensitization of nicotinic ACh receptors: shaping cholinergic signaling","volume":"28","author":"Giniatullin","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2006.04.005","article-title":"Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation","volume":"23","author":"Gotti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bcp.2007.05.023","article-title":"Heterogeneity and complexity of native brain nicotinic receptors","volume":"74","author":"Gotti","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.1207079","article-title":"Nicotinic acetylcholine receptor \u03b22 subunits in the medial prefrontal cortex control attention","volume":"333","author":"Guillem","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-3057(97)80001-9","article-title":"Safety of cotinine in humans: physiologic, subjective, and cognitive effects","volume":"57","author":"Hatsukami","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib32","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/j.0953-816X.2004.03377.x","article-title":"Nicotine reduces A\u03b2 in the brain and cerebral vessels of APPsw mice","volume":"19","author":"Hellstr\u00f6m-Lindahl","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib33","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1523\/JNEUROSCI.5038-09.2010","article-title":"Loss of \u03b17 nicotinic receptors enhances \u03b2-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease","volume":"30","author":"Hernandez","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib34","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12017-013-8242-1","article-title":"Nicotine prevents synaptic impairment induced by amyloid-\u03b2 oligomers through \u03b17-nicotinic acetylcholine receptor activation","volume":"15","author":"Inestrosa","year":"2013","journal-title":"Neuro Molecular Med."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1113\/jphysiol.2001.013847","article-title":"Rat nicotinic ACh receptor 7 and 2 subunits co-assemble to form functional heteromeric nicotinic receptor channels","volume":"540","author":"Khiroug","year":"2002","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib38","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"\u03b17 nicotinic receptor transduces signals to phosphatidylinositol 3-Kinase to block A \u03b2-Amyloid-induced neurotoxicity","volume":"276","author":"Kihara","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-122320","article-title":"Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia","volume":"35","author":"Kim","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/JMN:27:1:013","article-title":"Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide","volume":"27","author":"Lamb","year":"2005","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00167110","article-title":"Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells","volume":"40","author":"Le Nov\u00e8re","year":"1995","journal-title":"J.\u00a0Mol. Evol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-2010-101242","article-title":"Functional interactions of fibrillar and oligomeric amyloid-\u03b2 with Alpha7 nicotinic receptors in Alzheimer's disease","volume":"23","author":"Lilja","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib42","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1073\/pnas.081553598","article-title":"\u03b2-Amyloid peptide blocks the response of \u03b17-containing nicotinic receptors on hippocampal neurons","volume":"98","author":"Liu","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.3952-08.2009","article-title":"A\u00a0novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides","volume":"29","author":"Liu","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2202-13-155","article-title":"Functional alpha7beta2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid \u00df peptides","volume":"13","author":"Liu","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib45","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1523\/JNEUROSCI.6246-11.2012","article-title":"Glutamatergic synapse formation is promoted by \u03b17-containing nicotinic acetylcholine receptors","volume":"32","author":"Lozada","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.brainres.2004.07.016","article-title":"The \u03b17 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against \u03b2-amyloid1\u201342 toxicity in primary neuron-enriched cultures","volume":"1022","author":"Martin","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0014-5793(97)00600-5","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons","volume":"411","author":"Messi","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.902140206","article-title":"Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey","volume":"214","author":"Mesulam","year":"1983","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/mol.114.093377","article-title":"The novel \u03b17\u03b22-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization","volume":"86","author":"Moretti","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0378-5955(00)00124-6","article-title":"Cholinergic receptors: dual roles in transduction and plasticity","volume":"147","author":"Morley","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib52","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of A\u03b21\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90128-D","article-title":"Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention","volume":"57","author":"Muir","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mol.111.074088","article-title":"\u03b17\u03b22 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their \u03b17-\u03b17 interfaces","volume":"81","author":"Murray","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib55","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.00874.x","article-title":"Chronic nicotine treatment reduces \u03b2-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)","volume":"81","author":"Nordberg","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib57","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.0408500102","article-title":"Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease","volume":"102","author":"Oddo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnagi.2014.00166","article-title":"Effects of soluble \u03b2-amyloid on the release of neurotransmitters from rat brain synaptosomes","volume":"6","author":"Olivero","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib59","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1523\/JNEUROSCI.17-23-09165.1997","article-title":"Mice deficient in the \u03b17 neuronal nicotinic acetylcholine receptor lack \u03b1-Bungarotoxin binding sites and hippocampal fast nicotinic currents","volume":"17","author":"Orr-Urtreger","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12031-011-9509-3","article-title":"Allosteric modulator desformylflustrabromine relieves the inhibition of \u03b12\u00df2 and \u03b14\u00df2 nicotinic acetylcholine receptors by \u00df-amyloid1\u201342 peptide","volume":"45","author":"Pandya","year":"2011","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib61","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib63","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0197-4580(81)90032-4","article-title":"Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes","volume":"2","author":"Perry","year":"1981","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry","year":"1985","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib66","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/jnnp.50.6.806","article-title":"Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases","volume":"50","author":"Perry","year":"1987","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib67","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(88)90219-X","article-title":"Amyloid precursor protein in senile plaques of Alzheimer disease","volume":"2","author":"Perry","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00426713","article-title":"Scopolamine induced learning failures in man","volume":"52","author":"Petersen","year":"1977","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib69","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-01-j0003.2001","article-title":"\u03b2-Amyloid1\u201342 peptide directly modulates nicotinic receptors in the rat hippocampal slice","volume":"21","author":"Pettit","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib70","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1523\/JNEUROSCI.23-13-05531.2003","article-title":"The production of amyloid \u03b2 peptide is a Critical Requirement for the Viability of Central neurons","volume":"23","author":"Plant","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib71","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-\u03b2 positively modulates synaptic plasticity and memory in Hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib72","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjp.0706403","article-title":"Subtype-specific actions of \u03b2-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (\u03b17, \u03b14\u03b22, \u03b13\u03b24) expressed in Xenopus laevis oocytes","volume":"146","author":"Pym","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib74","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuroscience.2007.05.013","article-title":"The \u03b17 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice","volume":"148","author":"Ren","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-0173(96)00009-4","article-title":"Cognitive functions of cortical acetylcholine: toward a unifying hypothesis","volume":"23","author":"Sarter","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1037\/a0026227","article-title":"Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches","volume":"125","author":"Sarter","year":"2011","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib78","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004457","article-title":"Alzheimer's disease","volume":"3","author":"Selkoe","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib79","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11064-008-9629-5","article-title":"Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice","volume":"33","author":"Shim","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib80","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1471-4159.1986.tb12960.x","article-title":"Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia","volume":"46","author":"Shimohama","year":"1986","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib81","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ana.10292","article-title":"Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial","volume":"52","author":"Simons","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib82","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00213-014-3643-x","article-title":"Pregnenolone sulfate as a modulator of synaptic plasticity","volume":"231","author":"Smith","year":"2014","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainres.2008.06.062","article-title":"The nicotinic \u03b17 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-\u03b21\u201342","volume":"1227","author":"S\u00f8derman","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib84","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neulet.2010.10.049","article-title":"Activation of nicotinic \u03b17 acetylcholine receptor enhances long term potentation in wild type mice but not in APPswe\/PS1\u0394E9 mice","volume":"487","author":"S\u00f6derman","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0404.2006.00689.x","article-title":"Statin therapy in Alzheimer's disease","volume":"114","author":"Sparks","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib86","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/35052082","article-title":"Filamins as integrators of cell mechanics and signalling","volume":"2","author":"Stossel","year":"2001","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib88","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-7793.2000.00515.x","article-title":"Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons","volume":"527","author":"Sudweeks","year":"2000","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-291X(02)00429-1","article-title":"The inhibitory and facilitatory actions of amyloid-\u03b2 peptides on nicotinic ACh receptors and AMPA receptors","volume":"294","author":"Tozaki","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration","volume":"11","author":"Walsh","year":"2004","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib91","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"\u03b2-Amyloid1\u201342 binds to \u03b17 nicotinic acetylcholine receptor with high affinity implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","article-title":"Amyloid peptide A\u03b21-42 binds selectively and with picomolar affinity to \u03b17 nicotinic acetylcholine receptors","volume":"75","author":"Wang","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib93","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1523\/JNEUROSCI.6088-08.2009","article-title":"Dissociating \u03b2-amyloid from \u03b17 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes \u03b17 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain","volume":"29","author":"Wang","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib94","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.09.031","article-title":"S\u00a024795 Limits \u03b2-amyloid\u2013\u03b17 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies","volume":"67","author":"Wang","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib95","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","article-title":"Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A","volume":"32","author":"Wang","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/nlme.1996.3757","article-title":"The nucleus basalis magnocellularis cholinergic system: one hundred years of progress","volume":"67","author":"Wenk","year":"1997","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib97","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib98","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib99","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(86)90819-X","article-title":"Nicotinic acetylcholine binding sites in Alzheimer's disease","volume":"371","author":"Whitehouse","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/JMN:30:1:137","article-title":"Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters","volume":"30","author":"Wonnacott","year":"2006","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0301-0082(97)00094-4","article-title":"A\u00a0structural basis for memory storage in mammals","volume":"55","author":"Woolf","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib102","doi-asserted-by":"crossref","first-page":"37842","DOI":"10.1074\/jbc.M400335200","article-title":"\u03b2-Amyloid directly inhibits human \u03b14\u03b22-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells","volume":"279","author":"Wu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib103","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuropharm.2012.07.035","article-title":"Anti-amnesic effect of neurosteroid PREGS in A\u03b225\u201335-injected mice through \u03c31 receptor- and \u03b17nAChR-mediated neuroprotection","volume":"63","author":"Yang","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib104","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.npp.1300393","article-title":"Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.11.018_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euroneuro.2006.03.008","article-title":"Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice","volume":"17","author":"Young","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib106","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1096\/fj.07-8260com","article-title":"Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment","volume":"21","author":"Zanardi","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib107","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/cns.12190","article-title":"Simvastatin exerts antiamnesic effect in A\u03b225-35-injected mice","volume":"20","author":"Zhi","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib108","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.18-12-04461.1998","article-title":"Identification of four classes of brain nicotinic receptors using beta2 mutant mice","volume":"18","author":"Zoli","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.11.018_bib109","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/emboj\/18.5.1235","article-title":"Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors","volume":"18","author":"Zoli","year":"1999","journal-title":"EMBO J."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T08:32:07Z","timestamp":1566117127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":109,"alternative-id":["S0028390814004341"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}